Company profile
Life Stem Genetics Inc.
OTC: LIFS · Healthcare · Biotechnology
PublicHQ East Stroudsburg, NVCIK 0001556377Reports USD
#1161 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ 10GM —SS 34
v0.1 · 25/100 weight · pillars only
↑ Altman-Z, listing tenure · ↓ disclosure history, Piotroski F
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$39.1k
Employees
—
as of 2026-08-30
Market cap
$4.6k
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02013
Net income-$39.1k-$39.1k2013
Total assets$388$3882013
Liabilities$21.9k$21.9k2013
Equity-$21.5k-$21.5k2013
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Life Stem Genetics Inc.’s revenue?
Life Stem Genetics Inc. booked $0 in FY2013 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Safeplus International Holdings Limited——PAO Group, Inc.——Arno Therapeutics, Inc.——Innovation1 Biotech Inc.——ForU Holdings, Inc.——Xeno Transplants Corporation——Key facts
CEOGloria Simov
SectorHealthcare
IndustryBiotechnology
HeadquartersEast Stroudsburg, NV
ExchangeOTC: LIFS
Employees—
IPO date2013-10-22
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.